A major breakthrough in the treatment of amyotrophic lateral sclerosis, known as ALS, can potentially help stop the disease in its tracks in as much as half of the cases in the U.S., a Northeastern University scientist says.
Jeffrey Agar, associate professor of chemistry and pharmaceutical sciences at Northeastern, has spent the last 12 years studying the mechanism of ALS and researching ways to prevent its progression.
“You could consider it my life’s work,” he says. “I bet 12 years of my own life and countless number of years of others’ lives toward something that was so risky that everyone said it would never work.
“I am relieved that it all worked out.”
Read more from Northeastern Global News
Photo by Matthew Modoono/Northeastern University